1.Acanthamoeba sohi, n. sp., a pathogenic Korean isolate YM-4 from a freshwater fish.
The Korean Journal of Parasitology 2003;41(4):181-188
A new species of Acanthamoeba was isolated from a freshwater fish in Korea and tentatively named Acanthamoeba sp. YM-4 (Korean isolate YM-4). The trophozoites were 11.0-23.0 micrometer in length and had hyaline filamentous projections. Cysts were similar to those of A. culbertsoni and A. royreba, which were previously designated as Acanthamoeba group III. Acanthamoeba YM-4 can survive at 40 degrees C, and its generation time was 19.6 hr, which was longer than that of A. culbertsoni. In terms of the in vitro cytotoxicity of lysates, Acanthamoeba YM-4 was weaker than A. culbertsoni, but stronger than A. polyphaga. On the basis of the mortality of experimentally infected mice, Acanthamoeba YM-4 was found to be highly virulent. The isoenzymes profile of Acanthamoeba YM-4 was similar to that of A. royreba. An anti-Acanthamoeba YM-4 monoclonal antibody, McAY7, was found to react only with Acanthamoeba YM-4, and not with A. culbertsoni. Random amplified polymorphic DNA marker analysis and RFLP analysis of mitochondrial DNA and of 18S small subunit ribosomal RNA, placed Acanthamoeba YM-4 in a separate cluster on the basis of phylogenetic distances. Thus the Acanthamoeba Korean isolate YM-4 was identified as a new species, and assigned as Acanthamoeba sohi.
Acanthamoeba/*classification/genetics/isolation & purification/*pathogenicity
;
Amebiasis/parasitology/*veterinary
;
Animals
;
DNA, Mitochondrial/analysis
;
DNA, Protozoan/analysis
;
Fish Diseases/*parasitology
;
Gills/parasitology
;
Goldfish/*parasitology
;
Korea
;
Mice
;
Phylogeny
;
Polymorphism, Restriction Fragment Length
;
RNA, Ribosomal, 18S/genetics
;
Random Amplified Polymorphic DNA Technique
;
Virulence
2.Pathogenic free-living amoebae in Korea.
The Korean Journal of Parasitology 2004;42(3):93-119
Acanthamoeba and Naegleria are widely distributed in fresh water, soil and dust throughout the world, and cause meningoencephalitis or keratoconjunctivitis in humans and other mammals. Korean isolates, namely, Naegleria sp. YM-1 and Acanthamoeba sp. YM-2, YM-3, YM-4, YM-5, YM-6 and YM-7, were collected from sewage, water puddles, a storage reservoir, the gills of a fresh water fish, and by corneal washing. These isolates were categorized into three groups based on the mortalities of infected mice namely, highly virulent (YM-4), moderately virulent (YM-2, YM-5 and YM-7) and nonpathogenic (YM-3). In addition, a new species of Acanthamoeba was isolated from a freshwater fish in Korea and tentatively named Korean isolate YM-4. The morphologic characters of its cysts were similar to those of A. culbertsoni and A. royreba, which were previously designated as Acanthamoeba group III. Based on experimentally infected mouse mortality, Acanthamoeba YM-4 was highly virulent. The isoenzymes profile of Acanthamoeba YM-4 was similar to that of A. royreba. Moreover, an anti-Acanthamoeba YM-4 monoclonal antibody reacted only with Acanthamoeba YM-4, and not with A. culbertsoni. Random amplified polymorphic DNA marker analysis and RFLP analysis of mitochondrial DNA and of a 18S small subunit ribosomal RNA, placed Acanthamoeba YM-4 in a separate cluster based on phylogenic distances. Thus Acanthamoeba YM-4 was identified as a new species, and assigned Acanthamoeba sohi. Up to the year 2002 in Korea, two clinical cases were found to be infected with Acanthamoeba spp. These patients died of meningoencephalitis. In addition, one case of Acanthamoeba pneumonia with an immunodeficient status was reported and Acanthamoeba was detected in several cases of chronic relapsing corneal ulcer, chronic conjunctivitis, and keratitis.
*Acanthamoeba/classification/genetics/immunology/pathogenicity
;
Amebiasis/diagnosis/epidemiology/*parasitology/therapy
;
Animals
;
Antigens, Protozoan/analysis/genetics/immunology
;
DNA, Mitochondrial/analysis
;
DNA, Protozoan/analysis
;
Korea/epidemiology
;
Life Cycle Stages
;
*Naegleria/classification/genetics/immunology/pathogenicity
;
Phylogeny
;
Polymorphism, Restriction Fragment Length
;
Random Amplified Polymorphic DNA Technique/veterinary
;
Virulence/genetics
3.Interlocking Intramedullary Nailing of the Femoral Shaft Fracture: Technical Problems
Sung Il SHIN ; Baek Yong SONG ; Kyung Bum YOO
The Journal of the Korean Orthopaedic Association 1994;29(1):100-110
The use of the interlocking intramedullary nails expand the possibilities for treatment of femoral shaft fractures, as illustrated by consistent and satisfactory clinical results. However, the technique is relatively complex compared to conventional nails and frequently poses technical problems. A retrospective review was undertaken of twenty-eight patients with femoral shaft fractures which had technical problems after undergoing the closed reduction and internal fixation with interlocking intramedullary nail procedure. We studied the types of the problems. Their causes, the frequency of problems with various kinds of nails, and discussed solutions of the problems. There were 21 additional comminutions and intraop erative splinterings, 8 angular deformities, 3 malpositioned nails, 3 loosened distal locked screws, 2 brocken drill bits, and 1 femoral neck fracture. Bone-union was attained in all cases (28 patients), but the period of treatment to attain bone-union was protracted to an average of 6.8 (5-12) months. In 3 cases, the knee joint range of motion was of limited flexion, 70 to 90 degrees, but in all other cases full range of motion was realized. 7 cases required 2 or more operations. The hospitalization period was for an average of 3.6 months. In conclusion, the importance of careful preoperative planning and experienced surgical technique cannot be overemphasized because we could see no significant difference in the occurence of technical problems in several kinds of the nail.
Congenital Abnormalities
;
Femoral Neck Fractures
;
Fracture Fixation, Intramedullary
;
Hospitalization
;
Humans
;
Knee Joint
;
Range of Motion, Articular
;
Retrospective Studies
4.The effect of in vivo sensitization with various strains of BCG on the production of TNF by mouse peritoneal macrophages.
Hyung Il KIM ; Jeon Soo SHIN ; Nam Soo KIM ; Min Kyung CHU ; Se Jong KIM
Korean Journal of Immunology 1991;13(2):143-149
No abstract available.
Animals
;
Macrophages, Peritoneal*
;
Mice*
;
Mycobacterium bovis*
5.A Case of Majocchi Granuloma Caused by Microsporum canis Presented as Tinea Incognito.
Myong Il BAE ; Ki Heon JEONG ; Min Kyung SHIN ; Choong Rim HAW
Korean Journal of Dermatology 2015;53(9):735-737
No abstract available.
Granuloma*
;
Microsporum*
;
Tinea*
6.A Case of Penile Cutaneous Horn.
Young Il CHUN ; Je Ghon KIM ; Kyu Joong AHN ; Kyung Ho CHUN ; Yoo Shin LEE
Korean Journal of Dermatology 1985;23(4):536-538
Cutaneous horn is a clinical term for a circumscribed concial hyperkeratotic mass amounts to at least half of its largest diameter. The number of lesion may be single or multiple. We report herein a cases of penile cutaneous horn in a 22-year-old male. He had dark brownish colored conical shaped protruded mass on the penile shaft for about 2 months. We performed excisional biopsy and curettage. Histopathologic findings showed verruca vulgaris.
Animals
;
Biopsy
;
Curettage
;
Horns*
;
Humans
;
Male
;
Warts
;
Young Adult
7.Burden of Disease in Korea: Years of Life Lost due to Premature Deaths.
Hyejung CHANG ; Jae Il MYOUNG ; Youngsoo SHIN
Korean Journal of Preventive Medicine 2001;34(4):354-362
OBJECTIVES: The aim of this study was to estimate the burden of disease through an analysis of Years of Life Lost due to premature deaths, one component of the Disability-Adjusted Life Years (DALY). In addition, the cause of death statistics were adjusted to improve validity, and the results were compared with those of the Global Burden of Disease (GBD). METHODS: In closely following the approach taken in the original GBD study, most of the explicit assumptions and the value judgments were not changed. However, the statistics for some problematic concerns such as deaths of infants or those due to senility, were adjusted. Deaths, standard expected years of life lost (SEYLL), and potential years of life lost (PYLL) were computed using vital registration data compiled by the National Statistical Office. RESULTS: The burden for males is 1.8 and 2.3 times higher than that for females, according to SEYLL and PYLL, respectively. The proportions of deaths due to Group I, II, and III causes are 5.4%, 80.4%, and 14.3%, respectively, for PYLL, but in a major shift from Group II to III they are 6.3%, 66.2%, and 27.5%, respectively, for SEYLL. The proportion of Group III causes in Korea, 27.5%, is extremely high when compared to 10.1% for the world, 7.6% for developed countries, and 10.7% for developing countries. CONCLUSIONS: Estimation results showed that the total burden due to premature deaths is smaller than that for the entire world but larger than that for developed countries. The disease structure of Korea has changed to resemble that of developed countries. Also, an overly large portion of the total burden in Korea stems from injuries arising from car accidents.
Cause of Death
;
Cost of Illness
;
Developed Countries
;
Developing Countries
;
Female
;
Health Transition
;
Humans
;
Infant
;
Judgment
;
Korea*
;
Life Expectancy
;
Male
;
Mortality, Premature*
8.Non-invasive Cardiovascular Monitoring.
Korean Journal of Anesthesiology 1986;19(5):418-426
No abstract available.
9.A modified elution method for determining the presence of fetal red blood cells.
No Bum LEE ; Hye Kyung LEE ; Jung Hwan SHIN ; Moon Il PARK ; Sung Ro CHUNG ; Hyung MOON
Korean Journal of Perinatology 1992;3(2):72-76
No abstract available.
Erythrocytes*
10.Concomitant Boost Radiotherapy for Stage 3 Non - Small Cell Lung Cancer.
Kyung Hwan SHIN ; Charn Il PARK ; Young Soo SHIM ; Yung Jue BANG ; Sung Koo HAN
Journal of the Korean Cancer Association 1998;30(6):1110-1118
PURPOSE: This study was undertaken to evaluate the treatment outcome and side effects of accelerated radiotherapy (RT) using concomitant boost for stage III non-small cell lung cancer (NSCLC). METHODS: Between April 1991 and December 1994, 102 patients with stage III NSCLC who had the favorable prognostic factors by CALGB criteria, were treated with concomitant boost radiotherapy. Patients were treated with standard large fields to 54 Gy in 6 weeks. The boost treatment was administered concomitantly during the last 2 weeks with a dose of 13 Gy in 10 fractions. The interfraction interval was at least 6 hours. The total tumor dose was 66-70 Gy, given over 6 weeks. RESULTS: With 30 months median follow-up period for survivors, median survival was 15 months with 2 and 3-year overall survival rates of 34% and 19%, respectively. Thirty patients (29%) who had achieved complete remission after RT showed significantly better 2-year survival rates than those without complete remission (58% vs 22%, p 0.001). Local failure and distant metastases as the first or only failure occurred in 40 (44%) and 13 (14%), respectively, and ultimate local and distant failure rates were 45% and 29%, respectively. Although Grade IV esophageal complication of T-E fistula was observed in one patient, most patients with pulmonary complication showed mild, transient radiation pneumonitis. CONCLUSION: This result suggests that the treatrnent of stage III NSCLC with concomitant boost RT may improve survival rates without enhanced radiation induced toxicity compared with conventional RT. Further investigation of dose escalation by conformal radiotherapy of combining chemotherapy and accelerated RT is warranted.
Carcinoma, Non-Small-Cell Lung
;
Drug Therapy
;
Fistula
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Radiation Pneumonitis
;
Radiotherapy*
;
Radiotherapy, Conformal
;
Small Cell Lung Carcinoma*
;
Survival Rate
;
Survivors
;
Treatment Outcome